Quantcast

NYC Gazette

Tuesday, April 15, 2025

Osteochondral transplantation shows promise for young athletes with joint conditions

Webp yomi7ge7hsgg79jfw78bjfid9mte

Bryan T. Kelly, MD, MBA President and Chief Executive Officer | Hospital for Special Surgery

Bryan T. Kelly, MD, MBA President and Chief Executive Officer | Hospital for Special Surgery

Orthopedics Today has published findings on the potential effectiveness of osteochondral autologous transplantation for treating adolescent athletes with capitellar osteochondritis dissecans. The results were shared at the American Academy of Orthopaedic Surgeons Annual Meeting.

Dr. Jose M. Gutierrez-Naranjo, a research fellow at HSS, stated, "This study has identified synovial inflammation as a significant component of the disease process." He added, "We found [osteochondral autologous transplantation surgery (OATS)] to effectively restore the osteochondral architecture, leading to long-term pain relief and preserved function in adolescent athletes."

The study was conducted by Dr. Gutierrez-Naranjo, Robert N. Hotchkiss, MD, a hand and upper extremity surgeon at HSS, and their team. They reviewed data retrospectively from 17 adolescent athletes, including 15 males and two females, with a mean age of 14 years. These athletes underwent osteochondral autologous transplantation surgery between 2009 and 2023.

The detailed findings of the study can be accessed at healio.com.

MORE NEWS